Article
Emerging Roles of SIRT1 in Cancer Drug Resistance
17 Jan 2013
Abstract excerpt
Innate resistance to various therapeutic interventions is a hallmark of cancer. In recent years, acquired resistance has emerged as a daunting challenge to targeted cancer therapy, which abolishes the efficacy of otherwise successful targeting drugs. Cancer cells gain the resistance property through a variety of mechanisms in primary and metastatic cancers, involving cellular intrinsic and extrinsic factors....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
